FDA approves deep TMS device for depression

TEL AVIV (Reuters) - Brainsway received U.S. Food and Drug Administration approval for use of its Deep TMS (transcranial magnetic stimulation) device for the treatment of depression in patients who fail to respond to medication.
Source: Modern Medicine - Category: Journals (General) Source Type: news